Central Alabama Research — Birmingham, Alabama

Central Alabama Research is a clinical research site located in Birmingham, Alabama, United States 35209.

Crixeo Health Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.

Central Alabama Research has participated in 46 clinical trials with 13 currently active.

Therapeutic areas: Overweight, Obesity, Chronic Kidney Diseases.

Sponsors: Novo Nordisk A/S, Novartis Pharmaceuticals, Endogenex, Inc..

Sponsor Feasibility Report

Trust Score: 86/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Central Alabama Research?

Central Alabama Research has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Central Alabama Research conducted?

Central Alabama Research has 46 clinical trials on record, with 13 currently active. Their work covers Overweight, Obesity, Chronic Kidney Diseases.

Is Central Alabama Research accredited by Crixeo Health?

Yes — Central Alabama Research holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Central Alabama Research?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.